42 completed, 11 terminated, 9 active not recruiting, 9 recruiting. 85 Phase 1, 18 Phase 2.
Follow Blood Specimen Collection: new trials by email Literature Review of Blood Specimen Collection trials Research Report on Blood Specimen Collection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Neuronavigation-guided FUS-induced BBB Opening in Alzheimer's Disease Patients and Its Effects on Brain Amyloid and Tau Neuronavigation-guided single-element focused ultrasound transducer, Lumason, Magnetic Resonance Imaging (MRI) with or without gadolinium contrast agents - Alzheimer Disease, Early Onset | Phase 1 | Not yet recruiting | Columbia University | 6 | 2027-08-01 | 2026-05-13 |
| A Study of SRN-101 Administered Prior to Surgical Resection in Adults With Recurrent High-Grade Glioma. SRN-101, Blood Specimen Collection, Surgical Resection - Recurrent High-Grade Gliomas, Brain Neoplasm | Phase 1 | Not yet recruiting | Nicholas Butowski | 6 | 2026-11-15 | 2026-10-27 |
| Whole Body HER2 Quantification With 89Zr-Trastuzumab PET/CT to Asses Zr-trastuzumab Accumulation in HER2-mutated and HER2-overexpressing Metastatic Non-small Cell Lung Cancer PET imaging with ⁸⁹Zr-trastuzumab, Blood sampling for pharmacokinetics - Lung Cancer (NSCLC), HER2 Expression | Phase 1 | Recruiting | The Netherlands Cancer Institute | 20 | 2026-10-02 | 2026-10-20 |
| First-in Cancer-Type Phase I Study of FT536 for Recurrent WHO Grade 4 Astrocytoma FT536, Biopsy/ Intratumoral Injection/ Gross Tumor Resection, Blood/ Cerebrospinal Fluid/ Tumor Pathology - Astrocytoma, Glioblastoma | Phase 1 | Recruiting | Masonic Cancer Center, University of Minnesota | 9 | 2026-04-23 | 2026-05-01 |
| MicroRNA and MicroRNA Inhibitors Socket Study, Pilot Clinical Trial tooth extraction, CBCT scan, Anesthesia - Tooth Extraction Status Nos | Phase 1 | Withdrawn | Gustavo Avila-Ortiz DDS, MS, PhD | 2025-12-31 | 2019-07-17 | |
| Comparison of 177Lu-PSMA-617 and 225Ac-PSMA-617 177 Lutetium Prostate-Specific Membrane Antigen 617, Actinium-225 Prostate-Specific Membrane Antigen 617, Non-investigational, Prostatectomy - Prostate Cancer, Prostate Cancer (Diagnosis) | Phase 1 | Recruiting | Thomas Hope | 45 | 2025-07-08 | 2026-08-28 |
| Imaging of Solid Tumors Using 18F-TRX 18F-TRX, Positron Emission Tomography (PET)/Computerized tomography (CT), Tumor Biopsy - Solid Tumor, Solid Carcinoma | Phase 1 | Recruiting | Rahul Aggarwal | 56 | 2025-07-03 | 2026-07-23 |
| Evaluation of Cirrhotic Cardiomyopathy by Cardiac MRI in Patients Waiting for Liver Transplant. MRI, Blood sampling - Cirrhosis, Registered on Transplant List | Phase 1 | Recruiting | Centre Hospitalier Universitaire de Besancon | 60 | 2025-03-11 | 2026-07-22 |
| Study With [225Ac]Ac-FL-020 in mCRPC Participants [225Ac]Ac-FL-020, Blood samples for PK, [111In]In-FL-020 - Metastatic Castration-resistant Prostate Cancer | Phase 1 | Recruiting | Full-Life Technologies UK Limited | 50 | 2024-08-30 | 2026-05-26 |
| Development of a Bayesian Estimator for Calculating Plasma Iohexol Clearance Iohexol, pharmacokinetics - Kidney Function Test | Phase 1 | Unknown | Centre Hospitalier Universitaire de Saint Etienne | 48 | 2024-06-01 | 2024-04-29 |
| Pharmacokinetics of Intravaginal, Self-administered Artesunate Vaginal Pessaries Among Women in Kenya Artesunate pessary, blood draws for pharmacokinetics of the study drug - Cervix Cancer, Cervix Intraepithelial Neoplasia Grade 3 | Phase 1 | Completed | UNC Lineberger Comprehensive Cancer Center | 12 | 2024-05-29 | 2025-08-19 |
| Study of LYN-014 in Individuals With Opioid Use Disorder Who Are Stable on Methadone Therapy Levomethadone HCl, Methadone, Morphine Sulfate - Opioid Use Disorder, Moderate | Phase 1 | Withdrawn | Lyndra Inc. | 2022-02-28 | 2023-01-19 | |
| Human Immune Response to Ixodes Scapularis Tick Bites Xenodiagnosis Ticks, skin biopsy, blood draw - Tick-borne Diseases, Tick Resistance | Phase 1 / Phase 2 | Recruiting | National Institute of Allergy and Infectious Diseases (NIAID) | 60 | 2022-02-28 | 2026-09-22 |
| FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostate Cancer FOR46, Enzalutamide, Pegfilgrastim - Metastatic Castration-resistant Prostate Cancer, Prostate Cancer | Phase 1 / Phase 2 | Active not recruiting | Rahul Aggarwal | 44 | 2022-01-19 | 2026-09-17 |
| Circulating Tumor DNA in Melanoma Patients Blood Sampling for ctDNA Analysis - Melanoma, Skin Cancer | Phase 1 / Phase 2 | Active not recruiting | Institute of Oncology Ljubljana | 176 | 2021-11-01 | 2026-05-27 |
| Evaluating the Effect of NT-I7, a Long Acting Interleukin-7, to Increase Lymphocyte Counts and Enhance Immune Clearance of SARS-CoV-2 (COVID-19) NT-I7, Placebo, Blood for research purposes - COVID-19, SARS-CoV-2 | Phase 1 | Withdrawn | Washington University School of Medicine | 2021-07-31 | 2021-08-05 | |
| Glutamine PET Imaging Colorectal Cancer Carbon C 11 Glutamine, Fluorine F 18 L-glutamate Derivative BAY94-9392, Positron Emission Tomography - RAS Wild Type, Stage IV Colorectal Cancer | Phase 1 | Terminated | M.D. Anderson Cancer Center | 6 | 2021-04-27 | 2026-01-02 |
| The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer (64Cu)-NOTA-PSMAi-PEG-Cy5.5-C' dot tracer, PET/MRI/fluorescence imaging, Blood and urine sampling - Prostate Cancer | Phase 1 | Recruiting | Memorial Sloan Kettering Cancer Center | 16 | 2021-02-17 | 2026-06-10 |
| BreastVAX: Radiation Boost to Enhance Immune Checkpoint Blockade Therapy Hypofractionated radiotherapy, Pembrolizumab infusion, Blood and tissue sampling - Breast Cancer | Phase 1 / Phase 2 | Active not recruiting | Abramson Cancer Center at Penn Medicine | 27 | 2020-12-07 | 2026-03-10 |
| Neoadjuvant Nivolumab and Chemotherapy in Patients With Localized Triple-negative Breast Cancer Paclitaxel, Carboplatin, Nivolumab - Triple Negative Breast Cancer | Phase 1 / Phase 2 | Terminated | Washington University School of Medicine | 15 | 2020-11-19 | 2026-07-09 |
Showing 20 of 85. Sign in to see all of them.
Prostatic Neoplasms (5) · Lymphoma, Follicular (4) · Staphylococcal Infections (4) · Lymphoma (3) · Myelodysplastic Syndromes (3) · Neoplasms (3) · Acquired Immunodeficiency Syndrome (2) · Asthma (2) · Blast Crisis (2) · Brain Neoplasms (2) · Breast Neoplasms (2) · COVID-19 (2) · Gastrointestinal Stromal Tumors (2) · Glioblastoma (2) · Glioma (2)
Memorial Sloan Kettering Cancer Center (8) · Washington University School of Medicine (6) · GlaxoSmithKline (5) · Pfizer (4) · M.D. Anderson Cancer Center (3) · Merck Sharp & Dohme LLC (3) · National Institute of Allergy and Infectious Diseases (NIAID) (3) · Assistance Publique Hopitaux De Marseille (2) · Centre Hospitalier Universitaire Dijon (2) · Centre Oscar Lambret (2) · National Cancer Institute (NCI) (2) · National Institute of Mental Health (NIMH) (2) · Poitiers University Hospital (2) · Rahul Aggarwal (2) · University of Florida (2)
United States (52) · France (12) · Australia (5) · Belgium (3) · Canada (3) · China (2) · Germany (2) · Netherlands (2) · Kenya (1) · New Zealand (1) · Slovenia (1) · Spain (1) · Turkey (Türkiye) (1) · United Kingdom (1)
Masahiro Fujita, M.D. (2) · Rahul Aggarwal, MD (2) · Adriana R Marques, M.D. (1) · Alexander A. Vinks, Pharm.D., Ph.D. (1) · Andrew D Luster, M.D., Ph.D. (1) · Andrew Davis, M.D. (1) · Beth Christian, MD (1) · Brad Amendt, MS (1) · Chemtai Mungo, MD, MPH, FACOG (1) · Christopher Riedle, MD, PhD (1)
PMID 31993453, PMID 10831441, PMID 11069570, PMID 11297958, PMID 11468003, PMID 15379842, PMID 16553814, PMID 17083353, PMID 18035553, PMID 18424759, PMID 18557726, PMID 19066739, PMID 20236866, PMID 20921983, PMID 22527350, PMID 23352429, PMID 23607606, PMID 25707693, PMID 25778529, PMID 25847298, PMID 26222884, PMID 27519620, PMID 27866765, PMID 27916408, PMID 28143674, PMID 29427728, PMID 29606517, PMID 30064401, PMID 31401903, PMID 34312462, PMID 34656469, PMID 35041493, PMID 35164991, PMID 36028846, PMID 42612731, PMID 42784255, PMID 6354022, PMID 9764357
UM1CA186691 (2), 2008 (1), 2009 (1), 2016 (1), 4UH3DA050310-02 (1), K12HD043494 (1), K12HD103085 (1), P01CA015396 (1), P01CA049639 (1), P01CA148600 (1), P30CA006973 (1), P30CA012197 (1), P50CA100632 (1), P50CA196510 (1), R01AI047040 (1)